Short stature-brachydactyly-obesity-global developmental delay syndrome is a rare genetic condition that affects growth, learning, and body shape. People with the syndrome often have short height, short fingers and toes, higher body weight, and developmental or learning delays. Signs usually begin in infancy or early childhood and tend to be lifelong, though abilities can improve with support. Care focuses on therapies for development, weight management, and monitoring for related health issues, and advances in care mean people often manage well with treatment. If you or a loved one is facing short stature-brachydactyly-obesity-global developmental delay syndrome, talking with your healthcare provider can bring clarity and reassurance.
Overview
Short stature-brachydactyly-obesity-global developmental delay syndromeSymptoms
Short stature-brachydactyly-obesity-global developmental delay syndrome causes short height, short fingers and toes, early weight gain, and delays in speech, learning, and motor skills. Signs usually appear in infancy or early childhood. Some also have low muscle tone.
Outlook and prognosis
Many living with Short stature-brachydactyly-obesity-global developmental delay syndrome grow and learn at their own pace, often needing ongoing therapies and supports. With early services and regular check-ins, skills in mobility, communication, and self-care can improve. Long-term health depends on managing weight, sleep breathing issues, and orthopedic concerns.
Causes and risk factors
Short stature-brachydactyly-obesity-global developmental delay syndrome stems from a gene change present before birth. Many cases are new (de novo); having an affected parent or family history raises risk. Environment doesn’t cause it, but nutrition and care can influence severity.
Genetic influences
Genetics is central in Short stature-brachydactyly-obesity-global developmental delay syndrome; it results from rare, inherited changes affecting growth and neurodevelopment pathways. Variants can be de novo or passed in families, guiding recurrence risk. Genetic testing confirms diagnosis and informs care.
Diagnosis
Doctors suspect short stature-brachydactyly-obesity-global developmental delay syndrome based on clinical features and growth patterns. Genetic tests confirm the diagnosis, often by finding a disease-causing variant. Early genetic diagnosis of short stature-brachydactyly-obesity-global developmental delay syndrome can guide care and family counseling.
Treatment and drugs
Treatment for Short stature-brachydactyly-obesity-global developmental delay syndrome focuses on daily function and long‑term health. Care often combines nutrition and activity plans, physical/occupational/speech therapy, learning supports, and monitoring bone, heart, breathing, and metabolic health. Specialists may add targeted medicines for attention, behavior, sleep, seizures, or hormone issues.
Symptoms
People may notice everyday differences such as being shorter than peers, shorter fingers, a higher body weight, and delays in milestones like walking and talking. The changes are often subtle at first, blending into daily life until they become more noticeable. Early features of Short stature-brachydactyly-obesity-global developmental delay syndrome can include slower motor and speech milestones and hands with shorter, broader fingers.
Height is below average for age and sex compared with peers. This can mean reaching high shelves is harder and clothing sizes may run younger.
Clinicians call this brachydactyly, which means shorter fingers or toes. This can affect grip and fine-motor tasks like buttoning, writing, or using small tools.
Higher body weight is common and may begin in childhood. It can make movement less comfortable and may increase strain on joints and energy levels.
In Short stature-brachydactyly-obesity-global developmental delay syndrome, delays often affect motor, speech, and learning skills. Children may walk or talk later than peers and may need extra time and support to learn new tasks.
How people usually first notice Short stature-brachydactyly-obesity-global developmental delay syndrome?
Families often notice the first signs of Short stature–brachydactyly–obesity–global developmental delay syndrome in early childhood, when growth is slower than peers, fingers or toes look unusually short, and developmental milestones like first words or walking come later than expected. Pediatric check-ups may flag a shorter height curve, increasing weight (especially around the trunk), and small hands or feet on exam, prompting referral to genetics or neurology. For many, how the condition is first noticed is a combination of delayed skills, distinctive hand and foot features, and a growth pattern that doesn’t match typical child growth charts.
Types of Short stature-brachydactyly-obesity-global developmental delay syndrome
Short stature-brachydactyly-obesity-global developmental delay syndrome is a rare genetic condition. Current evidence points to a single recognizable disorder rather than multiple clinical variants, so “types of short stature-brachydactyly-obesity-global developmental delay syndrome” are not well defined. People may notice different sets of symptoms depending on their situation, such as learning differences being more apparent at school age while growth features show up earlier in childhood.
No recognized subtypes
Based on what is known today, there are no widely accepted clinical variants of this syndrome. Differences in height, hand/foot size, weight, or developmental skills tend to reflect individual variability rather than separate disease types.
What genetics can tell you about symptoms
Pathogenic variants in the RNF113A gene disrupt brain and skeletal development, which can lead to short stature, shortened fingers and toes, obesity, and global developmental delay. In many, these X-linked changes also bring feeding difficulties, low muscle tone, and speech or learning challenges.
Causes and risk factors
Short stature-brachydactyly-obesity-global developmental delay syndrome is caused by a change in a single gene that affects growth and brain development. Genes set the stage, but environment and lifestyle often decide how the story unfolds. The gene change often happens for the first time in a child and is not inherited, but it can rarely run in families. Family history is a risk you cannot change, while daily habits, sleep, diet, and activity can shape weight and metabolic health. Because early symptoms of Short stature-brachydactyly-obesity-global developmental delay syndrome can vary, genetic testing and counseling help confirm the cause and clarify future pregnancy risks.
Environmental and biological risk factors
Families often ask what drives the chance of Short stature-brachydactyly-obesity-global developmental delay syndrome. Awareness of both biological and environmental influences helps you feel prepared. Alongside questions about early symptoms of Short stature-brachydactyly-obesity-global developmental delay syndrome, it’s natural to wonder which risks are known and which are not. Here are the best-understood biological and environmental factors so far.
As sperm-producing cells keep dividing over time, small copying errors become more likely. This slightly raises the chance of conditions present from birth, including rare syndromes like Short stature-brachydactyly-obesity-global developmental delay syndrome. The absolute risk at any single age remains low.
Aging eggs have a higher chance of chromosome sorting issues. This can raise the overall chance of conditions present from birth, though most pregnancies at older ages are healthy.
High-dose radiation to the ovaries or testes before conception can damage reproductive cells. This may raise the chance of new changes in a future pregnancy, though everyday background radiation is not a concern.
Some chemotherapy medicines and pelvic radiation can affect egg or sperm quality. Care teams may advise a waiting period or fertility counseling before trying to conceive to reduce any added risk.
Genetic risk factors
Genetic changes are the main driver behind Short stature-brachydactyly-obesity-global developmental delay syndrome. Some risk factors are inherited through our genes. Many cases result from a single altered gene or a tiny missing or extra piece of DNA, and finding the exact change can also guide what to watch for, including early symptoms of Short stature-brachydactyly-obesity-global developmental delay syndrome. In other families, the change is new in the child (de novo), with parents unaffected.
Single-gene variants: An alteration in a single gene involved in bone growth, brain development, or weight regulation can cause Short stature-brachydactyly-obesity-global developmental delay syndrome. These variants can be inherited or occur for the first time in a child. Genetic testing can pinpoint the gene in many families.
Tiny DNA deletions: A small missing piece of a chromosome that removes one or more key genes can lead to Short stature-brachydactyly-obesity-global developmental delay syndrome. These microdeletions are often new in the child. Chromosomal microarray is a common test to detect them.
Tiny DNA duplications: A small extra piece of DNA that adds copies of certain genes can disrupt growth and neurodevelopment. Such duplications can sometimes produce a similar overall pattern to this syndrome. They may be inherited or arise de novo.
De novo changes: In many, the disease-causing change is not found in either parent, appearing for the first time in the child. This usually means a low chance of it happening again, though a small risk remains if a parent has germline mosaicism. A genetics team can explain recurrence numbers for your family.
Autosomal dominant: When the same genetic change is present in a parent, each child has a 50% chance to inherit it. Signs can be more or less noticeable from one family member to another. Ongoing follow-up helps tailor care to the child’s needs.
Variable expressivity: Features can range from subtle to more pronounced even within one family. People with the same risk factor can have very different experiences. This makes counseling and prognosis individualized.
Parental mosaicism: A parent may carry the change in a fraction of their egg or sperm cells but have no features. This can slightly increase the chance of having another child with the same condition after a de novo result. Special testing may be discussed if recurrence risk is a concern.
Family history: Having a first-degree relative with the confirmed causative change for Short stature-brachydactyly-obesity-global developmental delay syndrome raises the likelihood in siblings or future children. If family history is unclear, testing an affected child first provides the most useful starting point. Results can inform options in future pregnancies.
Lifestyle risk factors
This is a congenital condition; lifestyle habits do not cause it, but they can strongly influence symptoms, function, and complications. This overview explains how lifestyle affects Short stature-brachydactyly-obesity-global developmental delay syndrome and highlights practical areas families can modify. In particular, nutrition, activity, therapy routines, and sleep can affect weight, learning, behavior, and mobility. Below are the lifestyle risk factors for Short stature-brachydactyly-obesity-global developmental delay syndrome, with guidance tailored to its short stature, brachydactyly, obesity risk, and developmental needs.
Calorie-dense foods can accelerate weight gain in a body already prone to obesity. Balanced meals with protein and fiber help manage weight and lower insulin resistance risk. A dietitian can tailor plans to growth and micronutrient needs.
Regular, low-impact movement supports motor development and counters obesity in short stature. Activities may need adaptation for limb proportions and grip limits from brachydactyly. Physical therapy can guide safe strengthening and balance.
Poor or irregular sleep can worsen behavior, learning challenges, and appetite regulation. Consistent schedules and addressing snoring or possible apnea improve daytime function. Ask about a sleep study if there is loud snoring, pauses, or restless sleep.
Long periods of sitting and screen use promote further weight gain and deconditioning in this syndrome. Frequent movement breaks and active play improve endurance and coordination. Adaptive equipment can enable participation with peers.
Risk prevention
You can’t prevent the underlying genetics of Short stature-brachydactyly-obesity-global developmental delay syndrome, but you can lower the chance of complications and support healthier development. Prevention is about lowering risk, not eliminating it completely. Catching early symptoms of Short stature-brachydactyly-obesity-global developmental delay syndrome—like slow growth, delayed milestones, or snoring—can guide timely support.
See your pediatrician and specialists on a steady schedule to spot issues early. Screenings help track growth, learning, heart health, and sleep.
A registered dietitian can tailor meals to support steady growth and reduce excess weight gain. Balanced portions and regular meal times help prevent metabolic strain.
Daily, low-impact activity supports strength, coordination, and weight management. Activities like swimming or cycling are easier on small joints and bones.
Snoring, pauses in breathing, or restless sleep may signal obstructive sleep apnea. Early evaluation and treatment protect heart, brain, and daytime learning.
Transmission
Short stature-brachydactyly-obesity-global developmental delay syndrome is not contagious; you can’t catch it or pass it through everyday contact. It happens because of a change in a gene that is present from birth. In many families, this change arises for the first time in the child (a new, or de novo, change), but in some families it can be passed from a parent to a child. A genetics professional can explain how Short stature-brachydactyly-obesity-global developmental delay syndrome is inherited in your family and what that may mean for future pregnancies.
When to test your genes
Consider genetic testing if a child shows the combination of short stature, unusually short fingers/toes, early-onset obesity, and global developmental delay, or if these features run in your family. Test sooner when growth or developmental milestones are off course, to guide therapies and school supports. Adults with similar histories may also benefit for tailored care and family planning.
Diagnosis
For many, the first step comes when everyday activities start feeling harder—clothes fit differently because of weight gain, fingers seem shorter when doing up buttons, or school tasks take extra time. Doctors usually begin by looking at the overall pattern: shorter height for age, short fingers and toes, weight concerns, and delays in learning or motor skills. A genetic diagnosis of Short stature-brachydactyly-obesity-global developmental delay syndrome typically combines recognizable clinical features with confirmatory genetic testing. This helps distinguish it from more common causes of short stature or developmental delay.
The provider looks for a consistent pattern of short stature, short fingers and toes, and increased body weight. They’ll also note facial or body features that often travel together in syndromes.
Height, weight, and head size are plotted on growth charts to see how they track over time. Disproportion between limb length and trunk, or a high body mass index, can support the clinical picture.
Standardized tools check language, motor, learning, and daily living skills. Findings of global developmental delay help align the diagnosis with the overall pattern.
A three-generation family tree looks for relatives with short stature, brachydactyly, learning differences, or early weight gain. This can suggest a hereditary pattern or point to an unaffected background.
Stages of Short stature-brachydactyly-obesity-global developmental delay syndrome
Short stature-brachydactyly-obesity-global developmental delay syndrome does not have defined progression stages. It’s a lifelong genetic condition in which features like shorter height, small hands or feet, higher weight, and learning or developmental differences are present from early childhood and may shift with growth, but not in stepwise stages; early symptoms of Short stature-brachydactyly-obesity-global developmental delay syndrome are most often seen in growth patterns and developmental milestones. Doctors usually start with a conversation about your child’s growth, development, and family history, followed by a physical exam and careful measurements. Diagnosis is typically confirmed with genetic testing, and monitoring focuses on height/length and weight, nutrition, motor and language skills, and any associated health needs over time.
Outlook and prognosis
Looking ahead can feel daunting, but many living with Short stature-brachydactyly-obesity-global developmental delay syndrome can make steady gains with early therapies, tailored education plans, and structured routines. Daily life often centers on building communication, motor, and self-care skills; for example, speech therapy to expand vocabulary, or physical therapy to improve balance and walking. Early care can make a real difference, especially for early symptoms of Short stature-brachydactyly-obesity-global developmental delay syndrome such as delayed milestones or limited speech.
Doctors call this the prognosis—a medical word for likely outcomes. Most children continue to learn new skills into adolescence and adulthood, though progress may be slower than peers and some will need lifelong support. Growth differences and hand or foot changes tend to be stable physical features, while weight management usually needs ongoing attention through nutrition planning and activity. Everyone’s journey looks a little different. Current reports suggest life span can be near typical when medical issues like obesity-related complications, sleep apnea, or heart and breathing concerns are identified early and treated, but high-quality long-term data are limited.
With ongoing care, many people maintain a good quality of life, participate in family and community activities, and achieve personal milestones at their own pace. Understanding the prognosis can guide planning and help you prioritize therapies, school supports, and health checkups over time. Talk with your doctor about what your personal outlook might look like, including what to monitor and how to adjust the care plan as needs change.
Long-term effects
People living with Short stature-brachydactyly-obesity-global developmental delay syndrome tend to show features that start in early childhood and continue into adulthood. Long-term effects vary widely, and not everyone will experience the same pattern or severity. Over time, daily routines may shift around growth differences, hand shape, learning pace, and weight-related health. Doctors often describe these as long-term effects or chronic outcomes.
Height usually remains below average from childhood into adulthood. Growth may slow earlier than peers, leading to a shorter adult height.
Short fingers and toes can be lifelong. For some, hand shape may affect fine finger movements and tasks that require precision.
A tendency toward higher body weight can persist, with risks like insulin resistance or high blood pressure over time. In Short stature-brachydactyly-obesity-global developmental delay syndrome, these metabolic concerns may emerge in adolescence or adulthood.
Global developmental delay often evolves into mild to moderate learning differences. Many continue to need support with reasoning, reading, or problem-solving in school and adult life.
How is it to live with Short stature-brachydactyly-obesity-global developmental delay syndrome?
Living with Short stature–brachydactyly–obesity–global developmental delay syndrome often means needing extra support for movement, learning, and daily routines, while also celebrating steady, hard-won progress. Many face challenges with fine motor tasks due to short fingers, fatigue with longer walks because of short stature and weight, and slower skill acquisition in school and self-care, so therapies and adapted tools become part of everyday life. Families, teachers, and friends usually play a central role—planning appointments, practicing strategies from therapy, and adjusting expectations—yet they also see how consistency, patience, and inclusive environments can unlock meaningful independence and connection. For many, the rhythm is different, not lesser: with tailored medical care, nutritional guidance, and educational supports, daily life becomes more predictable, safer, and more empowering for everyone involved.
Treatment and drugs
Treatment for Short stature-brachydactyly-obesity-global developmental delay syndrome focuses on managing day-to-day needs and preventing complications rather than curing the condition. Care typically involves a team: pediatricians, endocrinologists, geneticists, therapists, dietitians, and educators working together on growth monitoring, weight management, learning support, and skill-building therapies such as speech, occupational, and physical therapy. Medicines may be used for specific issues, for example managing appetite and weight, addressing behavioral symptoms, treating sleep problems, or correcting hormone imbalances if present; a doctor may adjust your dose to balance benefits and side effects. Regular hearing, vision, dental, and orthopedic checks help track features like small hands and feet or bone differences, while individualized education plans support learning and communication. Supportive care can make a real difference in how you feel day to day, and research is ongoing on the genetic underpinnings to guide future therapies.
Non-drug treatment
Living day to day with Short stature-brachydactyly-obesity-global developmental delay syndrome often means focusing on movement, communication, learning, and healthy growth. Care plans usually mix therapies that build skills with practical supports at home and school. Non-drug treatments often lay the foundation for progress, helping people reach milestones at their own pace. A team approach—with therapists, educators, and family—works best over time.
Coordinated therapies in infancy and toddler years can boost motor, speech, and social skills. Starting early helps shape daily routines that support development.
Guided exercises improve balance, coordination, and strength for walking, climbing stairs, and play. Therapists can tailor plans to short stature and joint alignment.
Skill-building activities make self-care like dressing, feeding, and handwriting easier. Hand therapy can adapt tasks for short fingers and limited reach.
Sessions target speech sounds, language understanding, and social communication. Therapists may also work on feeding and swallowing if needed.
Your genes may have an impact on how drugs work for you
Medicines for short stature–brachydactyly–obesity–global developmental delay syndrome can work differently from person to person because genetic changes affect how the body absorbs, activates, and clears drugs. Pharmacogenetic testing may guide safer doses and choices, while doctors still adjust based on response.
Pharmacological treatments
Medicines for Short stature-brachydactyly-obesity-global developmental delay syndrome focus on easing specific problems rather than changing the underlying genetics. Choices are tailored to early symptoms of Short stature-brachydactyly-obesity-global developmental delay syndrome, such as excess weight, attention challenges, sleep issues, or seizures. Not everyone responds to the same medication in the same way. Doctors review age, growth, and other health conditions before prescribing.
Liraglutide and semaglutide can help adolescents with Short stature-brachydactyly-obesity-global developmental delay syndrome who are living with obesity lose weight. These prescription injections may also improve blood sugar and cholesterol. Nausea is common early on, so doses are increased slowly.
Orlistat blocks some fat absorption and may support modest weight loss in teens. It can cause oily stools and gas, and fat‑soluble vitamins may drop, so a multivitamin at a different time of day is usually advised.
Metformin can improve insulin sensitivity and may curb weight gain linked to insulin resistance. It is taken by mouth and can cause stomach upset that often eases over time.
Methylphenidate or amphetamine stimulants may improve focus and reduce hyperactivity. Atomoxetine is a non‑stimulant option; appetite, sleep, and heart rate are monitored during treatment.
Genetic influences
Short stature-brachydactyly-obesity-global developmental delay syndrome is thought to arise from changes in one or more genes that help direct skeletal growth, weight regulation, and brain development. In many rare genetic syndromes, the gene change occurs for the first time in the child (de novo), but if a parent carries the same change, it can be passed on. Family history is one of the strongest clues to a genetic influence. Genetic testing for short stature-brachydactyly-obesity-global developmental delay syndrome may include a focused gene panel or broader testing to look for a single-gene change or a small missing or extra piece of DNA. Results can help explain the diagnosis, show whether parents or siblings carry the same change, and clarify the chance of the condition happening again in a future pregnancy. Even within the same family, features and severity can vary, so pinpointing the exact gene change can guide care plans and support.
Is Short stature-brachydactyly-obesity-global developmental delay syndrome genetic?
Genetics is central in Short stature-brachydactyly-obesity-global developmental delay syndrome; it results from rare, inherited changes affecting growth and neurodevelopment pathways. Variants can be de novo or passed in families, guiding recurrence risk. Genetic testing confirms diagnosis and informs care.
Pharmacogenetics—how genetics influence drug effects
Treatment plans often need to be customized, because growth, weight, and learning needs vary widely in short stature-brachydactyly-obesity-global developmental delay syndrome. The same genetic changes behind the condition can also shape how the body handles medicine—affecting the dose that reaches the brain and other organs, how drugs spread in a smaller body with more body fat, and how quickly the liver or kidneys clear them. This can be important when dosing growth therapies, managing appetite and weight, or using medicines for attention, mood, sleep, or seizures, since benefits and side effects may appear at lower or higher doses than usual. Genetic testing can sometimes identify how your body responds to certain antidepressants, ADHD medicines, pain relievers, or seizure medicines, helping the team choose a starting dose and monitor more closely. Weight, height, age, nutrition, and other prescriptions still play a big role, so doctors will adjust doses over time and check levels or heart rhythm tests when needed. Sharing a simple log of medication response in short stature-brachydactyly-obesity-global developmental delay syndrome can help spot patterns early and guide safer dose changes.
Interactions with other conditions
People living with short stature-brachydactyly-obesity-global developmental delay syndrome often face added health issues tied to weight, sleep, and learning, and these can influence each other in everyday life. Doctors call it a “comorbidity” when two conditions occur together. Obstructive sleep apnea and low muscle tone can sap energy and focus, which may make therapies and school support harder, while poor sleep can also worsen weight gain. Weight-related conditions—such as high blood pressure, high blood sugar (type 2 diabetes), and fatty liver disease—can shape choices about medicines, surgery, and anesthesia, and they merit regular screening in both children and adults. Joint and mobility concerns from short stature and brachydactyly may overlap with flat feet, scoliosis, or hip problems, so coordinated care with physiotherapy and orthopedics can help protect comfort and independence. Because early symptoms of short stature-brachydactyly-obesity-global developmental delay syndrome may not reveal risks like seizures, thyroid problems, or hearing and vision issues, ongoing checkups—and a quick review of whether any behavioral or seizure medicines might affect weight or sleep—can lower complications and improve quality of life.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns that a few children in a generation stayed much shorter than peers, had small hands and feet, gained weight easily, and needed extra support with learning and daily skills. Grandparents might recall a cousin who wore the smallest shoes in the class, or a sibling who struggled with speech milestones but had a warm, social personality. These lived observations came long before a unifying name or explanation existed.
From early theories to modern research, the story of Short stature-brachydactyly-obesity-global developmental delay syndrome reflects how medicine assembles scattered clues into a clearer picture. Early medical notes focused on features a doctor could see: markedly short height, shortened fingers and toes, round facial features, and early-onset weight gain. Teachers and parents highlighted what they noticed day to day—later walking or first words, and support needs in school. Over time, descriptions became more consistent, and clinicians realized these features often travel together in the same child rather than occurring by chance.
Initially understood only through symptoms, later studies began to connect outward features with underlying biology. As genetic testing advanced in the late 20th and early 21st centuries, researchers could compare DNA changes in children who shared the same pattern of findings. This helped separate Short stature-brachydactyly-obesity-global developmental delay syndrome from look-alike conditions and confirmed that it represents a distinct clinical picture. With each decade, teams refined growth charts, documented typical ranges for hand and foot size, and described common developmental profiles, which made earlier recognition possible.
Once considered rare, now recognized as part of a broader group of genetic growth and neurodevelopmental syndromes, it has gathered a steadier place in medical references and patient guides. Not every early description was complete, yet together they built the foundation of today’s knowledge. Families contributed by sharing histories across generations, allowing researchers to trace patterns and suggest when to offer genetic counseling or specialized therapies.
In recent decades, awareness has grown in both pediatrics and genetics clinics. This has led to more coordinated care—linking growth monitoring, nutrition and physical activity plans, occupational and speech therapy, and, when helpful, targeted evaluations of bones and hormone function. Knowing the condition’s history helps explain why some adults were never given a clear diagnosis in childhood, while many children today are identified earlier and connected to services sooner. The history of Short stature-brachydactyly-obesity-global developmental delay syndrome is still being written, but each step has moved care from scattered observations to practical support for daily life.